Mr Espeed Khoshbin is a Consultant Cardiac Surgeon and a senior lecturer at the University of Manchester, United Kingdom. He is a Fellow of the Intercollegiate Royal Collages of Surgeons of Great Britain and Ireland. He trained in cardiopulmonary transplantation through the national fellowship scheme at Freeman Hospital United Kingdom and traveling (ISHLT) scholarship in the United States (UCLA). He has a doctoral research degree in ECMO. His scientific interest is in reducing the systemic inflammatory response associated with extracorporeal circulation. He also has experience with the use of robotic technology in cardiac surgery. He is a faculty member of the international aspects of cardiothoracic transplantation course in Newcastle and the Manchester University speciality training academy and cadaveric course. He is a reviewer for the National Institute of Health Research, member of the Cochrane heart and editor/reviewer for a number of peer review journals.
Dr. Omer Senbaklavaci is a Lead Surgeon of Lung Transplant Program in University Medical Center Freiburg, Germany. He also served as a Director for Lung Transplant Program at Acibadem University, Turkey (Nov 2015- Oct 2016). He was a Chair of Thoracic Surgical Division and Head of Lung Transplant Program, Consultant Thoracic at Universitätsmedizin Mainz, Germany (June 2009- May 2014). He was a consultant Thoracic and Transplant Surgeon in The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital. He has the Fellowship of Royal College of Surgeon of England. He trained in Vienna, Austria and in Bochum, Germany. He was the Surgical Lead of the Lung Transplant Program at Freeman Hospital. His first appointment as Consultant Cardiothoracic Surgeon in Klagenfurt, Austria 2004-2009. He had a special interest in minimally invasive lung transplantation and lung preservation which gained 2011 National Thoracic Surgical Price of the German Society for Thoracic and Cardiovascular Surgery with his experimental study.
Dr. Pavlos Papoulidis is a Cardiothoracic Surgeon and a Senior fellow in St James’s Hospital LTH. He is a member of British Society of Cardiothoracic Surgery and had a fellowship in European Association for Cardio-Thoracic Surgery (EACTS), Hellenic Society of Thoracic and Cardiovascular Surgeons, The Cardio-Thoracic network (CTS net) and The Hellenic Society of Trauma. He was a Senior fellow at Royal Wolverhampton Hospital. He also served as an Associate specialist/ Trust grade Specialist Doctor, Cardiothoracics, UHCW. In all of his posts he was performing thoracic mainly (in total 10.5 years: 6.5 years in UK) and occasionally cardiac procedures. His main interest is in robotic surgery, VATS and airway Management/ LVRS and also in pectus repairs and trauma surgery. He completed his online training for robotic surgery and all practical tests (hours). In JCUH he was introduced and performed micro-lobectomies, pectus repairs, radio-guided pulmonary nodules resection and robotic thoracic surgery. As a member of stuff in Royal Brompton Hospital he was exposed to minimal invasive techniques thoracic surgery (VATS lobectomy), bronchoscopy, mediastinoscopy, LASER metastasectomy.
Farooq A Shiekh is the Chair of Research & Head, Department of Biochemistry, GMC, Baramulla, India. He also served Chair of Research & Professor, Department of Basic Medical Sciences, Avalon University School of Medicine, Curacao, Netherlands Antilles. Dr. Shiekh obtained his PhD in biomedical sciences- the biochemical characterization of small particles, from one of the primer medical center the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India in 2005. In order to pursue his great interests in the field of nanoparticles he joined at Mayo Clinic, Rochester, MN, USA, as a fellow (2007-2009) and trained as a senior scientist at Faculte of de Medecine, National Center for Scientific Research (CNRS) and WHO collaborative center, La Timone Hospital, Marseille, France (2010-2012). His area of research is advancing ‘nanocarriers’ for combined targeted medicine, in order to enhance efficacy of drug delivery to reach untargetable complex tumor sites. Dr. Shiekh is currently the consulting editor for the International Journal of Nanomedicine and is associated with many other scientific organizations. He has many years of diverse teaching and research experience from renowned medical institutions of world repute.